Effective Inhibition of MYC-Amplified Group 3 Medulloblastoma Through Targeting EIF4A1.
Zhao Y, Li T, Tian S, Meng W, Sui Y, Yang J, Wang B, Liang Z, Zhao H, Han Y, Tang Y, Zhang L, Ma J.
Zhao Y, et al. Among authors: zhao h.
Cancer Manag Res. 2020 Dec 3;12:12473-12485. doi: 10.2147/CMAR.S278844. eCollection 2020.
Cancer Manag Res. 2020.
PMID: 33299354
Free PMC article.